Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer.
Min Woo LeeSun Kyung JeonWoo Hyun PaikJeong Hee YoonIjin JooJeong Min LeeSang Hyub LeePublished in: Journal of cachexia, sarcopenia and muscle (2024)
In patients with metastatic pancreatic cancer, body composition mostly changed during the first 2 months after starting chemotherapy, and the prognostic factors associated with OS differed between males and females. Initial and longitudinal changes of body composition are associated with OS of metastatic pancreatic cancer.